Latest Stock Buy or Sell? Make More Informed Decisions!

Doesn’t think we have seen the full benefits of the whole synergy between Shoppers and Loblaw’s. Also, feels the issues that have occurred for about 5 years have been really turned around and solved.

Unlike some of their competitors, they do banking the old-fashioned traditional way. Has a very, very large deposit base. This is going to really require a play on the interest rate environment for it to work. With a 3% dividend, you get paid to wait.

They surprised him with the exposure that they had to energy. That has really driven them down so far this year. They have a pretty good capital position. Asia is still a big lever for them. He is lukewarm on the name.

This owns about 30 brands including Skippy peanut butter. They are getting into the healthier food. It came on his radar screen because of its really long ascent, a very low volatile name. It was up about 500% for about 10 years and the dividend rose 300%. Then it had a big pull back of about 25%. They reported and actually beat earnings 2 weeks ago. The street turned on them. Dividend yield of 1.68%.

A more speculative name in that it doesn’t trade very regularly. They are in the foreign currency exchange products in North America. Has an online website and technology that the banks can use as well. They’ve been working on trying to get their Schedule 1 bank license, for the distribution of banknotes.

Biotech’s have gone through a lot of negativity. Seasonally, right around now is when this sector starts to get accumulated by the professionals, because we get into the fall and Christmas area where there is a lot of biotech conferences. Typically, about 70% of all announcements are made somewhere between November and January in Biotechs.